Share sale costs – can VAT on deal costs now be reclaimed?

Share Sale Costs - Can VAT On Deal Costs Now Be Reclaimed?

Date:

Category:

Share this article:

As any VAT expert will tell you, VAT on costs can only be reclaimed where the costs have a direct and immediate link with a particular taxable supply, so where the costs relate to exempt activities or are not at all related to taxable business activity, then the VAT on these costs is not reclaimable. This principle has been subject to much debate and litigation over the years resulting in the evolution of this basic concept and additional complexity for businesses having to decide how much VAT is deductible on restructuring and deal costs.

The recent Upper Tribunal case of HMRC v Hotel La Tour (‘HLT’) has shed some further light on this complex area and may provide a basis for businesses that have made share disposals, to revisit the value of VAT restriction they applied at the time.

The Facts

HLT was the parent company operating a wholly owned subsidiary, Hotel La Tour Birmingham Ltd (‘HLTB’). Both HLT and HLTB were part of a VAT group with HLT as a representative member. HLTB owned and operated a hotel and HLT provided it with management services.

In 2015, HLT decided to develop a new hotel for an estimated cost of £34m and set out to raise funds to do so. After due consideration, it was decided that this would be best achieved by selling its shares in HLTB and to borrow the remainder. It was accepted by HMRC that the proceeds received from the share sale HLTB were to be used towards developing the new hotel.

HLT reclaimed the VAT it incurred on the cost of selling its shares in HLTB, but HMRC denied the recovery on the basis that the costs related to the exempt sale of the shares and that it is not possible to look beyond this immediate supply when attributing the costs.

The First Tier Tribunal (‘FTT’)

The FTT held that various case law, including the Supreme Court decision of Frank A Smart, suggested that a more objective assessment of the intended use of the funds should be taken, and how those funds are obtained – from loans or from share sales – should not necessarily impede VAT recovery.

With this in mind, and in light of the reliable, objective evidence on hand that the aim of the share sale was to raise funds for HLT’s development of a new hotel, the FTT concluded that the costs incurred on the share disposal were business overheads of HLT and VAT deductible.

The Upper Tribunal (‘UT’)

HMRC appealed the FTT decision on the grounds that the share sale costs could only be seen to have a direct and immediate link with HLT’s taxable activities if they were ‘cost components’ of the company’s outputs, and that they were ‘used for the purposes of transactions’.

The UT rejected HMRC’s submissions on the basis that the ‘direct and immediate link’ requirements set out in early VAT case law have evolved and that an objective approach is now more appropriate. Also, the fact that other litigation (‘Kretztechnik’) has found that VAT on costs relating to share issues (which are ‘outside the scope’ of VAT) can be viewed as business overheads and potentially VAT deductible, would mean that denying the same treatment for costs relating to exempt share sales would jeopardise the fiscal neutrality requirement of the VAT regime, given that they are essentially the same kind of transaction.

What Now?

Care should be taken as it is not yet known if HMRC will appeal this decision further. However, it would be prudent to revisit the circumstances around previous share sales and consider if this binding UT decision offers scope to reclaim elements of VAT that have previously been restricted.

If costs were incurred some time ago (but within the 4-year cap for retrospective VAT adjustments) and if, after reviewing the details, your circumstances broadly reflect the critical points of this case, thought should be given to collating and submitting a protective claim.

Also, any plans for restructuring or for any future share sales should be reviewed with this case in mind, to see what positive impact it might have.

For assistance to assess the potential opportunity arising from this significant case, contact Mike Trotman in our specialist VAT team at [email protected] – call 0330 124 7740 or use the form below.

This website uses cookies

With these cookies, we and third parties can collect information about you and your internet behaviour, both within and outside our website. Based on this, we and third parties adjust the website, our communication, and advertisements to your interests and profile. You can read more information in our cookie statement.

If you opt for acceptance, we will place all cookies. If you opt for rejection, we will only place functional and analytical cookies. You can adjust your preferences at a later time.

Accept Reject More options

This website uses cookies

With these cookies, we and third parties can collect information about you and your internet behaviour, both within and outside our website. Based on this, we and third parties adjust the website, our communication, and advertisements to your interests and profile. You can read more information in our cookie statement.

Functional cookies
Arrow down

Functional cookies are essential for the proper functioning of our website. They allow us to enable basic functions such as page navigation and access to secure areas. These cookies do not collect personal information and cannot be disabled.

Analytical cookies
Arrow down

Analytical cookies help us gain insight into how visitors use our website. We collect anonymised data about page interactions and navigation, enabling us to continuously improve our site.

Marketing cookies
Arrow down

Marketing cookies are used to track visitors when they visit different websites. The goal is to display relevant advertisements to the individual user. By allowing these cookies, you help us show you relevant content and offers.

Accept all Save

Name

Subtitle
Developer
Location
They are focussed on creating a future-focused and relationship-driven culture, that keeps its promises to you, our team members, and partners.
Xeinadin